Using non-invasive technology and research, AOA体育平台 will be able to examine a patient鈥檚 DNA, pinpointing exactly what kind of cancer they may have. This precision will lead to even better informed clinical decision-making.
From diagnostics and screening through treatment to monitoring and aftercare, our patients will benefit from ever more streamlined pathways. Our multi-disciplinary teams will be able to find the very best treatment for each patient, with a truly personalised plan.
Patients can expect high-quality testing, quick turnaround time and affordable pricing, with the security of a partnership that is bringing together two organisations dedicated to innovation in cancer care for the benefit of patients.
Lina Patel, Head of Cancer Services at AOA体育平台, said: 鈥淭his exciting partnership will provide a robust platform to offer precise and personalised medicine. Our ultimate aim is to ensure more patients survive and hopefully thrive beyond receiving treatment for cancer.
鈥淭ogether, through collaboration and sharing best practice, we will advance clinical excellence in cancer care, ensuring more and more patients can benefit.鈥�
Dr Vineet Datta, Executive Director at Datar Cancer Genetics, said: 鈥淲e are delighted to partner with AOA体育平台. This collaboration will provide advanced cancer genomics to the patient community, and we will work closely with AOA体育平台鈥檚 Oncology team to support better informed clinical decision-making.鈥�
Cancer is one of the biggest causes of death worldwide, accounting for nearly one in six deaths in 2020 according to the . One in two people in the UK will be diagnosed with some form of cancer during their lifetime.
As a leading independent hospital and charity, AOA体育平台鈥檚 aim is to advance clinical excellence and share best practice worldwide, for the betterment of patient care.
The new partnership brings together two organisations that are dedicated to finding ever better ways to detect and treat cancers.
Find out more about cancer care at AOA体育平台 here.